High-dose-rate brachytherapy as monotherapy for prostate cancer

Brachytherapy

Volumn 13, Issue 6, 2014, Pages 529-541

  Demanes, D Jeffrey ^a   Ghilezan, Michel I ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Michigan Healthcare Professionals 21 Century Oncology   (United States)

Author keywords

High dose rate brachytherapy; Monotherapy; Prostate; Prostate cancer; Radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CONTROL; DOSIMETRY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HIGH RISK POPULATION; HUMAN; KNOWLEDGE; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONAL EXPERIENCE; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TRANSRECTAL ULTRASONOGRAPHY; UROGENITAL TRACT DISEASE; BLOOD; DISEASE FREE SURVIVAL; MORTALITY; PROCEDURES; PROSTATIC NEOPLASMS; RADIOGRAPHY;

BRACHYTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84908270705     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2014.03.002     Document Type: Article

References (67)

1. Stromberg J., Martinez A., Gonzalez J., et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 1995, 33:161-171.
2. Kovacs G., Galalae R., Wirth B., et al. Improvement of interstitial brachytherapy for localized prostate neoplasms with a new implantation technique. Strahlenther Onkol 1995, 171:685-688.
3. Martinez A., Gonzalez J., Stromberg J., et al. Conformal prostate brachytherapy: Initial experience of a phase I/II dose-escalating trial. Int J Radiat Oncol Biol Phys 1995, 33:1019-1027.
4. Mate T.P., Gottesman J.E., Hatton J., et al. High dose-rate afterloading 192Iridium prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 1998, 41:525-533.
5. Kovacs G., Galalae R., Loch T., et al. Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer. Strahlenther Onkol 1999, 175(Suppl. 2):87-88.
6. Demanes D.J., Rodriguez R.R., Altieri G.A. High dose rate prostate brachytherapy: The California Endocurietherapy (CET) method. Radiother Oncol 2000, 57:289-296.
7. Martinez A.A., Gustafson G., Gonzalez J., et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 2002, 53:316-327.
8. Martinez A.A., Kestin L.L., Stromberg J.S., et al. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: The William Beaumont phase II dose-escalating trial. Int J Radiat Oncol Biol Phys 2000, 47:343-352.
9. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 2001, 49:61-69.
10. Rodriguez R.R., Demanes D.J., Altieri G.A. High dose rate brachytherapy in the treatment of prostate cancer. Hematol Oncol Clin North Am 1999, 13:503-523.
11. Yoshioka Y., Nose T., Yoshida K., et al. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 2000, 48:675-681.
12. Edmundson G.K., Rizzo N.R., Teahan M., et al. Concurrent treatment planning for outpatient high dose rate prostate template implants. Int J Radiat Oncol Biol Phys 1993, 27:1215-1223.
13. Edmundson G.K., Yan D., Martinez A.A. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. Int J Radiat Oncol Biol Phys 1995, 33:1257-1263.
14. White E.C., Kamrava M.R., Demarco J., et al. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry. Int J Radiat Oncol Biol Phys 2013, 85:543-548.
15. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999, 43:1095-1101.
16. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002, 52:6-13.
17. Fowler J.F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 2005, 44:265-276.
18. Peddada A.V., Jennings S.B., Faricy P.O., et al. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection. J Urol 2007, 178:1963-1967.
19. Monroe A.T., Faricy P.O., Jennings S.B., et al. High-dose-rate brachytherapy for large prostate volumes (> or=50cc)-Uncompromised dosimetric coverage and acceptable toxicity. Brachytherapy 2008, 7:7-11.
20. Yamada Y., Bhatia S., Zaider M., et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 2006, 5:157-164.
21. Hermesse J., Biver S., Jansen N., et al. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate. Int J Radiat Oncol Biol Phys 2010, 76:269-276.
22. Holly R., Myrehaug S., Kamran A., et al. High-dose-rate prostate brachytherapy in a patient with bilateral hip prostheses planned using megavoltage computed tomography images acquired with a helical tomotherapy unit. Brachytherapy 2009, 8:70-73.
23. Hsu I.C., Pickett B., Shinohara K., et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: Potential for dose escalation. Int J Radiat Oncol Biol Phys 2000, 46:851-858.
24. Jo Y., Fujii T., Hara R., et al. Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy-Preliminary results. BJU Int 2012, 109:835-839.
25. Lee B., Shinohara K., Weinberg V., et al. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2007, 67:1106-1112.
26. Tharp M., Hardacre M., Bennett R., et al. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy 2008, 7:231-236.
27. De Cicco L., Vavassori A., Cattani F., et al. Salvage high dose rate brachytherapy after primary external beam irradiation in localized prostate cancer: A case report. Tumori 2009, 95:553-556.
28. Niehoff P., Loch T., Nurnberg N., et al. Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy. Brachytherapy 2005, 4:141-145.
29. Simnor T., Li S., Lowe G., et al. Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer. Radiother Oncol 2009, 93:253-258.
30. Schmid M., Crook J.M., Batchelar D., et al. A phantom study to assess accuracy of needle identification in real-time planning of ultrasound-guided high-dose-rate prostate implants. Brachytherapy 2013, 12:56-64.
31. Kovalchuk N., Furutani K.M., Macdonald O.K., et al. Dosimetric effect of interfractional needle displacement in prostate high-dose-rate brachytherapy. Brachytherapy 2012, 11:111-118.
32. Huang Y., Miller B., Doemer A., et al. Online correction of catheter movement using CT in high-dose-rate prostate brachytherapy. Brachytherapy 2013, 12:260-266.
33. Holly R., Morton G.C., Sankreacha R., et al. Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy. Brachytherapy 2011, 10:299-305.
34. Foster W., Cunha J.A., Hsu I.C., et al. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy. Int J Radiat Oncol Biol Phys 2011, 80:85-90.
35. Kolkman-Deurloo I.K., Roos M.A., Aluwini S. HDR monotherapy for prostate cancer: A simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation. Radiother Oncol 2011, 98:192-197.
36. Seppenwoolde Y., Kolkman-Deurloo I.K., Sipkema D., et al. HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging. Radiother Oncol 2008, 86:114-119.
37. Hoskin P.J., Colombo A., Henry A., et al. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update. Radiother Oncol 2013, 107:325-332.
38. Yamada Y., Rogers L., Demanes D.J., et al. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy 2012, 11:20-32.
39. Yoshioka Y., Konishi K., Sumida I., et al. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions. Int J Radiat Oncol Biol Phys 2011, 80:469-475.
40. Konishi K., Yoshioka Y., Isohashi F., et al. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2009, 75:1003-1007.
41. Komiya A., Fujiuchi Y., Ito T., et al. Early quality of life outcomes in patients with prostate cancer managed by high-dose-rate brachytherapy as monotherapy. Int J Urol 2013, 20:185-192.
42. Demanes D.J., Martinez A.A., Ghilezan M., et al. High-dose-rate monotherapy: Safe and effective brachytherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2011, 81:1286-1292.
43. Bossi A. Quelle modalite pour la curietherapie du cancer de prostate. Cancer Radiother 2010, 14(6-7):488-492.
44. Grills I.S., Martinez A.A., Hollander M., et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 2004, 171:1098-1104.
45. Martinez A.A., Demanes J., Vargas C., et al. High-dose-rate prostate brachytherapy: An excellent accelerated-hypofractionated treatment for favorable prostate cancer. Am J Clin Oncol 2010, 33:481-488.
46. Mark R.J., Anderson P.J., Akins R.S., et al. Interstitial high-dose-rate brachytherapy as monotherapy for early stage prostate cancer; median 8-year results in 301 patients. Brachytherapy 2010, 9(Suppl. 23):102.
47. Rogers C.L., Alder S.C., Rogers R.L., et al. High dose brachytherapy as monotherapy for intermediate risk prostate cancer. J Urol 2012, 187:109-116.
48. Ghadjar P., Keller T., Rentsch C.A., et al. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. Brachytherapy 2009, 8:45-51.
49. Hoskin P., Rojas A., Lowe G., et al. High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence. Int J Radiat Oncol Biol Phys 2012, 82:1376-1384.
50. Barkati M., Williams S.G., Foroudi F., et al. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A phase II trial. Int J Radiat Oncol Biol Phys 2012, 82:1889-1896.
51. Zamboglou N., Tselis N., Baltas D., et al. High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: Treatment evolution and mature results. Int J Radiat Oncol Biol Phys 2013, 85:672-678.
52. Ghilezan M., Martinez A., Gustason G., et al. High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: Preliminary toxicity data. Int J Radiat Oncol Biol Phys 2012, 83:927-932.
53. Prada P.J., Jimenez I., Gonzalez-Suarez H., et al. High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: Treatment description and preliminary results. Brachytherapy 2012, 11:105-110.
54. Hoskin P., Rojas A., Ostler P., et al. High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity. Radiother Oncol 2014, 110:268-271.
55. Kamrava M., Chung M.P., Kayode O., et al. Focal high-dose-rate brachytherapy: A dosimetric comparison of hemigland vs. conventional whole-gland treatment. Brachytherapy 2013, 12:434-441.
56. Reed G., Cunha J.A., Noworolski S., et al. Interactive, multi-modality image registrations for combined MRI/MRSI-planned HDR prostate brachytherapy. J Contemp Brachytherapy 2011, 3:26-31.
57. Yamada Y., Kollmeier M.A., Pey X., et al. A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy 2014, 13:111-116.
58. Katz A.J., Santoro M., Ashley R., et al. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 2010, 10:1.
59. Martin A., Gaya A. Stereotactic body radiotherapy: A review. Clin Oncol (R Coll Radiol) 2010, 22:157-172.
60. Lo S.S., Fakiris A.J., Chang E.L., et al. Stereotactic body radiation therapy: A novel treatment modality. Nat Rev Clin Oncol 2010, 7:44-54.
61. Friedland J.L., Freeman D.E., Masterson-McGary M.E., et al. Stereotactic body radiotherapy: An emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 2009, 8:387-392.
62. Abdel-Wahab M., Pollack A. Radiotherapy: Encouraging early data for SBRT in prostate cancer. Nat Rev Urol 2009, 6:478-479.
63. Hossain S., Xia P., Chuang C., et al. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys 2008, 35:4041-4048.
64. King C.R., Brooks J.D., Gill H., et al. Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 2009, 73:1043-1048.
65. Teh B.S., Ishiyama H., Mathews T., et al. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. Discov Med 2010, 52:255-262.
66. Fuller D.B., Naitoh J., Lee C., et al. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: Dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys 2008, 70:1588-1597.
67. Spratt D.E., Scala L.M., Folkert M., et al. A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer. Brachytherapy 2013, 12:428-433.